Dec 16, 2020 / 01:00PM GMT
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Galapagos webcast. (Operator Instructions) I'm must advise you that this conference is being recorded today, Wednesday, the 16th of December, 2020.
I would now like to hand the conference over to your speaker today, Elizabeth Goodwin. Please go ahead, madam.
Elizabeth Goodwin - Galapagos NV - VP of IR
Thank you all for joining us today to discuss the revised terms for filgotinib with Gilead. I'm Elizabeth Goodwin, Investor Relations. And this webcast is accessible via the Galapagos website homepage and will be available for replay later on today.
Sell-side analysts and professional investors will be invited to pose a question at the end of the call. And if you want to have your question included, you could dial in now on 32 for Belgium, 27933847, and the code is 7689939. You can also consult other numbers in our press release.
I'd like to remind everyone we'll be making forward-looking statements during today's webcast. These forward-looking statements include
Galapagos NV & Gilead Sciences Inc to Announce New Commercialization and Development Agreement for Rheumatoid Arthritis Treatment Call Transcript
Dec 16, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers